These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8700037)

  • 21. Post-stenting intravascular brachytherapy trials on hypercholesterolemic rabbits using 32P liquid sources: implications for prevention of in-stent restenosis.
    Wilczek K; Walichiewicz P; Petelenz B; Jache W; Jochem J; Tomasik A; Bilski P; Snietura M; Wodniecki J
    Cardiovasc Intervent Radiol; 2002; 25(4):307-13. PubMed ID: 12042990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intervention and clinical aspects combined with endovascular irradiation of intimal hyperplasia of the vascular system].
    Liermann D; Berkefeld J; Herrmann G; Schopohl B; Strassmann G; Adamitz I; Kollath J
    Radiologe; 1994 Sep; 34(9):524-33. PubMed ID: 7800801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carotid artery stent placement for atherosclerotic disease: rationale, technique, and current status.
    Phatouros CC; Higashida RT; Malek AM; Meyers PM; Lempert TE; Dowd CF; Halbach VV
    Radiology; 2000 Oct; 217(1):26-41. PubMed ID: 11012420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pathology: radiation-induced coronary artery disease in man and animals.
    Virmani R; Farb A; Carter AJ; Jones RM
    Semin Interv Cardiol; 1998; 3(3-4):163-72. PubMed ID: 10406688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioactive 32P-stent for in-stent restenosis in the porcine model.
    Kollum M; Cottin Y; Kim HS; Bhargava B; Tio FO; Vodovotz Y; Waksman R
    Cardiovasc Radiat Med; 1999; 1(4):376-7. PubMed ID: 10828568
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose model for a beta-emitting stent in a realistic artery consisting of soft tissue and plaque.
    Janicki C; Duggan DM; Gonzalez A; Coffey CW; Rahdert DA
    Med Phys; 1999 Nov; 26(11):2451-60. PubMed ID: 10587232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy.
    Prestwich WV; Nunes J; Kwok CS
    J Nucl Med; 1989 Jun; 30(6):1036-46. PubMed ID: 2738686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restenosis in gold-coated renal artery stents.
    Nolan BW; Schermerhorn ML; Powell RJ; Rowell E; Fillinger MF; Rzucidlo EM; Wyers MC; Whittaker D; Zwolak RM; Walsh DB; Cronenwett JL
    J Vasc Surg; 2005 Jul; 42(1):40-6. PubMed ID: 16012450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.
    Leichner PK; Cash SA; Backx C; Durand RE
    Radiology; 1981 Oct; 141(1):193-9. PubMed ID: 7291525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose model for stent-based delivery of a radioactive compound for the treatment of restenosis in coronary arteries.
    Janicki C; Hwang CW; Edelman ER
    Med Phys; 2003 Oct; 30(10):2622-8. PubMed ID: 14596298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dose dependent effects of the combined beta-gamma-emitter 188Rhenium on the growth of human vessel wall cells].
    Henning E; Dittmann H; Wiskirchen J; Bantleon R; Kehlbach R; Claussen CD; Duda SH
    Rofo; 2004 Mar; 176(3):404-8. PubMed ID: 15026955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetry study of Re-188 liquid balloon for intravascular brachytherapy using polymer gel dosimeters and laser-beam optical CT scanner.
    Wuu CS; Schiff P; Maryanski MJ; Liu T; Borzillary S; Weinberger J
    Med Phys; 2003 Feb; 30(2):132-7. PubMed ID: 12607830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of stents and stent grafts to salvage angioplasty failures in patients with hemodialysis grafts.
    Vesely TM; Amin MZ; Pilgram T
    Semin Dial; 2008; 21(1):100-4. PubMed ID: 18251965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brachytherapy for the prevention of neointimal hyperplasia in the canine inferior vena cava after stent placement.
    Isota M; Kaminou T; Sakai Y; Nakamura K; Yamada R
    Osaka City Med J; 2002 Jun; 48(1):59-67. PubMed ID: 12375698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
    Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC
    Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose perturbation of a novel cobalt chromium coronary stent on 32P intravascular brachytherapy: a monte carlo study.
    Mourtada F; Horton JL
    Med Phys; 2005 Jan; 32(1):268-74. PubMed ID: 15719978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stents: strengthening the chief weapon against restenosis.
    Phillips L
    Hosp Technol Ser; 1996 Apr; 15(5):2-3. PubMed ID: 10158285
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of a voxel model of the heart for dosimetry.
    Fonseca KR; Trindade BM; Campos TP
    Artif Organs; 2011 May; 35(5):459-64. PubMed ID: 21595712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The radioactive stent--any chance of a resurrection?
    Arab A; Bode C; Hehrlein C
    Eur Heart J; 2001 Aug; 22(15):1245-7. PubMed ID: 11465956
    [No Abstract]   [Full Text] [Related]  

  • 40. Reoxygenation of human coronary smooth muscle cells suppresses HIF-1alpha gene expression and augments radiation-induced growth delay and apoptosis.
    Grumann T; Arab A; Bode C; Guttenberger R; Hehrlein C
    Strahlenther Onkol; 2006 Jan; 182(1):16-21. PubMed ID: 16404516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.